Home> Products> erdosteine clinical efficacy evidence

{ "products": [ { "_id": "69747bdec522c2b149071d3b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sodium Chloride Inhalation Solution USP 3% w/v", "description": "SODICHLOR 3% is a sterile, preservative-free hypertonic saline inhalation solution specifically formulated to help manage respiratory conditions characterized by thick, tenacious mucus secretions. This pharmaceutical-grade formulation contains 3% sodium chloride in purified water, offering a concentration three times higher than normal saline, designed to work through osmotic principles to improve airway clearance and respiratory function.\nAs a trusted therapeutic agent in respiratory care, SODICHLOR 3% represents a non-antibiotic approach to managing chronic respiratory conditions, making it an invaluable tool for patients suffering from cystic fibrosis, chronic obstructive pulmonary disease (COPD), bronchiectasis, and other conditions where mucus clearance is compromised. The solution is administered via nebulization, allowing the medication to reach deep into the bronchial passages where it can exert its therapeutic effects most effectively.\nHow SODICHLOR 3% Works\nThe mechanism of action behind SODICHLOR 3% is elegantly simple yet highly effective. When nebulized and inhaled, the hypertonic saline solution creates an osmotic gradient in the airways. This means that the higher salt concentration in the solution draws water from the surrounding tissues into the airway surface liquid layer. This influx of water hydrates the mucus, making it less viscous and sticky, which significantly improves the ability to cough up and clear secretions from the lungs.\nAdditionally, SODICHLOR 3% helps restore the normal salt and water balance on airway surfaces, which is particularly important in conditions like cystic fibrosis where this balance is naturally disrupted. The solution also stimulates ciliary beat frequency, enhancing the natural cleaning mechanism of the respiratory tract. By improving mucociliary clearance, SODICHLOR 3% helps reduce the bacterial burden in the airways, potentially decreasing the frequency of respiratory infections and exacerbations.\nPrimary Uses and Applications\nSODICHLOR 3% is prescribed for various respiratory conditions where enhanced mucus clearance is clinically beneficial:\nCystic Fibrosis Management: Perhaps the most well-established use, SODICHLOR 3% has become a cornerstone therapy for patients with cystic fibrosis. Regular use helps thin the abnormally thick mucus characteristic of this genetic condition, improving lung function and quality of life while reducing the risk of pulmonary exacerbations.\nChronic Obstructive Pulmonary Disease: For COPD patients who struggle with excessive mucus production and poor clearance, SODICHLOR 3% provides relief by facilitating easier expectoration and improving breathing comfort.\nBronchiectasis: This condition, characterized by permanently damaged and widened airways that trap mucus, benefits significantly from hypertonic saline therapy. SODICHLOR 3% helps clear the pooled secretions that contribute to recurrent infections.\nPost-Operative Respiratory Care: Following certain surgical procedures, particularly thoracic surgeries, SODICHLOR 3% may be used to prevent mucus plugging and atelectasis by maintaining adequate airway hydration.\nSputum Induction: In diagnostic settings, SODICHLOR 3% can be used to induce sputum production for laboratory testing when patients cannot spontaneously produce adequate samples.\nKey Benefits of SODICHLOR 3%\nThe therapeutic advantages of SODICHLOR 3% extend across multiple dimensions of respiratory health:\nEnhanced Mucus Clearance: The primary benefit is the dramatic improvement in the ability to clear thick, sticky mucus from the airways. Patients often report easier breathing and more productive coughing within minutes of treatment.\nImproved Lung Function: Clinical studies have demonstrated that regular use of hypertonic saline solutions like SODICHLOR 3% can lead to measurable improvements in pulmonary function tests, including forced expiratory volume (FEV1) and forced vital capacity (FVC).\nReduced Infection Frequency: By promoting better mucus clearance and reducing bacterial colonization in the airways, SODICHLOR 3% may help decrease the frequency of respiratory infections and disease exacerbations, leading to fewer hospitalizations.\nNon-Antibiotic Therapy: In an era of increasing antibiotic resistance, SODICHLOR 3% offers a mechanical rather than chemical approach to managing respiratory symptoms, making it a valuable addition to any treatment regimen without contributing to resistance patterns.\nCost-Effective Treatment: Compared to many specialized respiratory medications, SODICHLOR 3% represents a relatively affordable therapeutic option that can be used long-term without prohibitive expense.\nQuality of Life Enhancement: Patients using SODICHLOR 3% regularly often report significant improvements in their daily activities, exercise tolerance, and overall sense of well-being due to easier breathing and reduced respiratory distress.\nCompatibility with Other Treatments: SODICHLOR 3% can be safely used alongside other respiratory medications, including bronchodilators, corticosteroids, and antibiotics, as part of a comprehensive treatment plan.\nPotential Side Effects and Considerations\nWhile SODICHLOR 3% is generally well-tolerated, patients should be aware of potential side effects:\nCommon Side Effects: The most frequently reported adverse effects include throat irritation, coughing (especially initially), unpleasant taste, and mild wheezing or chest tightness. These effects are typically transient and often diminish with continued use as the body adapts to the therapy.\nBronchospasm: Some patients, particularly those with hyperreactive airways or asthma, may experience bronchospasm (sudden narrowing of the airways) during or after treatment. This is why healthcare providers often recommend using a bronchodilator before SODICHLOR 3% administration.\nTemporary Oxygen Desaturation: In some cases, especially in patients with severe lung disease, temporary decreases in blood oxygen levels may occur immediately after treatment, though levels typically return to baseline within 30 minutes.\nNasal Congestion and Rhinorrhea: Some patients may experience nasal stuffiness or runny nose following inhalation therapy.\nLess Common Effects: Headache, nausea, dizziness, or voice changes may occasionally occur but are generally mild and self-limiting.\nPatients with certain conditions such as uncontrolled hypertension, severe electrolyte imbalances, or recent hemoptysis should use SODICHLOR 3% only under close medical supervision. As with any medical treatment, it's essential to discuss your complete medical history with your healthcare provider before beginning therapy.\nConclusion\nSODICHLOR 3% represents a scientifically sound, clinically proven approach to managing respiratory conditions complicated by thick mucus secretions. Its mechanism of action—leveraging osmotic principles to hydrate and mobilize airway secretions—addresses a fundamental problem faced by millions of patients with chronic respiratory diseases. The substantial body of evidence supporting its efficacy, combined with its favorable safety profile and cost-effectiveness, makes SODICHLOR 3% an indispensable component of modern respiratory care.", "price": 540.0, "discountamount": 162.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2283, "imageuri": "https://productimages.withfloats.com/actual/69747be5cf228670cde34180.png", "tileimageuri": "https://productimages.withfloats.com/tile/69747be5cf228670cde34180.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-24T07:59:26.118Z", "updatedon": "2026-01-24T07:59:26.118Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sodium-chloride-inhalation-solution-usp-3-w-v/2283", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SODICHLOR 3%", "category": "Respiratory", "tags": [ "sodium chloride inhalation solution usp 3 percent", "sodium chloride 3% nebulizer solution", "sodium chloride 3% respiratory solution", "sodium chloride inhalation solution usp 3% price", "buy sodium chloride 3% inhalation solution", "sodium chloride 3% nebulizer solution manufacturer", "sodium chloride inhalation solution usp 3% benefits", "sodium chloride inhalation solution usp 3% benefits", "sodium chloride inhalation solution usp 3% dosage", "sodium chloride inhalation solution usp 3% side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "696b676455604cb93507be01", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Lactobacillus rhamnosus GG (ATCC 53103)", "description": "MINIBIOTIC GG is a scientifically validated probiotic formulation containing Lactobacillus rhamnosus GG (ATCC 53103), one of the most extensively researched probiotic strains in the world. This probiotic strain is known for its exceptional ability to survive stomach acid, adhere to the intestinal lining, and support a healthy balance of gut microflora.\n\nModern lifestyles, frequent antibiotic use, stress, poor dietary habits, and infections often disrupt the natural balance of beneficial bacteria in the gut. MINIBIOTIC GG is designed to restore and maintain this balance, supporting digestive health, immunity, and overall well-being. Due to its proven safety profile and clinical evidence, Lactobacillus rhamnosus GG is widely recommended for children, adults, and the elderly under medical guidance.\n\nUses of MINIBIOTIC GG\n\nMINIBIOTIC GG is commonly used to support and manage a variety of gastrointestinal and immune-related conditions. It helps replenish beneficial gut bacteria and strengthens intestinal health.\n\nKey Uses Include:\n\nManagement and prevention of antibiotic-associated diarrhea\n\nSupport in acute and chronic diarrhea\n\nMaintenance of healthy gut flora\n\nImprovement of digestive comfort and bowel regularity\n\nSupport for immune system function\n\nAdjunct therapy in gastrointestinal infections\n\nSupport in lactose digestion and intolerance\n\nRestoration of gut balance during stress or illness\n\nThis probiotic is often recommended during or after antibiotic therapy to reduce digestive disturbances and promote faster recovery of the gut microbiome.\n\nHow Lactobacillus rhamnosus GG Works\n\nLactobacillus rhamnosus GG works by colonizing the intestinal tract and creating a protective barrier against harmful microorganisms. Once ingested, the probiotic adheres to the gut lining and begins to multiply, producing beneficial substances such as lactic acid that help maintain an optimal intestinal environment.\n\nIt also:\n\nInhibits the growth of pathogenic bacteria\n\nEnhances intestinal barrier function\n\nModulates immune responses\n\nSupports healthy digestion and nutrient absorption\n\nThis mechanism makes MINIBIOTIC GG effective in maintaining long-term gut health and preventing recurrent digestive issues.\n\nKey Benefits of MINIBIOTIC GG\n1. Supports Digestive Health\n\nMINIBIOTIC GG helps regulate bowel movements, reduces bloating, and supports overall digestive comfort. It is particularly beneficial for individuals experiencing frequent digestive upset.\n\n2. Reduces Antibiotic-Associated Side Effects\n\nAntibiotics can disrupt normal gut flora, leading to diarrhea and abdominal discomfort. Lactobacillus rhamnosus GG helps restore beneficial bacteria and minimizes these side effects.\n\n3. Strengthens the Immune System\n\nA large portion of the immune system resides in the gut. MINIBIOTIC GG supports immune defenses by enhancing gut-associated immune responses and reducing susceptibility to infections.\n\n4. Helps Manage Diarrhea\n\nClinical studies have shown Lactobacillus rhamnosus GG to be effective in reducing the duration and severity of acute infectious diarrhea, especially in children.\n\n5. Supports Gut Health in Children and Adults\n\nThis probiotic strain has been extensively studied in pediatric and adult populations, making it suitable for a wide age range when used as directed.\n\n6. Improves Gut Barrier Function\n\nMINIBIOTIC GG helps maintain the integrity of the intestinal lining, reducing gut permeability and supporting overall gastrointestinal health.\n\n7. Promotes Microbial Balance\n\nRegular use helps maintain a healthy balance between beneficial and harmful bacteria, reducing the risk of gut dysbiosis.\n\nSide Effects of MINIBIOTIC GG\n\nMINIBIOTIC GG is generally safe and well-tolerated when used as recommended. However, like all probiotic supplements, some individuals may experience mild and temporary side effects, especially during the initial days of use.\n\nCommon Side Effects\n\nMild bloating\n\nGas or flatulence\n\nAbdominal discomfort\n\nThese effects usually resolve on their own as the body adjusts to the probiotic.\n\nRare Side Effects\n\nDigestive discomfort in individuals with sensitive gastrointestinal systems\n\nVery rare cases of infection in severely immunocompromised individuals\n\nPatients with weakened immune systems, serious underlying medical conditions, or those undergoing intensive medical treatments should use probiotics only under medical supervision.\n\nPrecautions and Safety Information\n\nUse under medical advice, especially in infants, elderly patients, or immunocompromised individuals\n\nStore as directed to maintain probiotic viability\n\nDo not exceed the recommended dosage\n\nNot intended as a substitute for a balanced diet\n\nAlways consult a healthcare professional before starting MINIBIOTIC GG, particularly if you are pregnant, breastfeeding, or taking other medications.\n\nWhy Choose MINIBIOTIC GG?\n\nMINIBIOTIC GG stands out due to its clinically proven strain, high safety profile, and effectiveness across various digestive and immune-related conditions. The inclusion of Lactobacillus rhamnosus GG (ATCC 53103) ensures consistent performance and reliable health benefits.\n\nKey reasons to choose MINIBIOTIC GG:\n\nOne of the most researched probiotic strains globally\n\nProven efficacy in digestive and immune support\n\nSuitable for children and adults\n\nSupports gut health during and after antibiotic therapy\n\nConclusion\n\nMINIBIOTIC GG, powered by Lactobacillus rhamnosus GG (ATCC 53103), is a trusted probiotic solution for maintaining and restoring gut health. Its clinically proven benefits in digestive support, immune enhancement, and diarrhea management make it a valuable addition to modern healthcare routines.", "price": 600.0, "discountamount": 180.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2277, "imageuri": "https://productimages.withfloats.com/actual/696b67664c7de3212cee39c8.png", "tileimageuri": "https://productimages.withfloats.com/tile/696b67664c7de3212cee39c8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-17T10:41:40.563Z", "updatedon": "2026-01-17T10:55:49.759Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/lactobacillus-rhamnosus-gg-atcc-53103-/2277", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MINIBIOTIC GG", "category": "GASTROLOGYRANGE", "tags": [ "lactobacillus rhamnosus gg atcc 53103 probiotic", "lactobacillus rhamnosus gg strain atcc 53103", "lactobacillus rhamnosus gg probiotic supplement", "lactobacillus rhamnosus gg capsule uses", "lactobacillus rhamnosus gg oral probiotic", "lactobacillus rhamnosus gg dosage for adults", "lactobacillus rhamnosus gg pediatric use", "lactobacillus rhamnosus gg clinical dosage", "lactobacillus rhamnosus gg microbiome support", "lactobacillus rhamnosus gg role in gut microbiota", "lactobacillus rhamnosus gg probiotic research", "lactobacillus rhamnosus gg side effects", "is lactobacillus rhamnosus gg safe for long term use", "lactobacillus rhamnosus gg bulk supplier", "lactobacillus rhamnosus gg pharmaceutical manufacturer", "lactobacillus rhamnosus gg third party manufacturing", "lactobacillus rhamnosus gg probiotic manufacturer india", "Atorvastatin 10 mg and Clopidogrel 75 mg capsules", "lactobacillus rhamnosus gg formulation manufacturer", "lactobacillus rhamnosus gg probiotic in india", "lactobacillus rhamnosus gg capsules price", "lactobacillus rhamnosus gg probiotic near me", "lactobacillus rhamnosus gg probiotic india supplier" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69623e6c95697555dd1afd67", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Esomeprazole and Itopride", "description": "ESMOSTRUM IT: Comprehensive Product Guide\nProduct Overview\nESMOSTRUM IT is an advanced pharmaceutical formulation that combines two potent active ingredients—Esomeprazole and Itopride—to provide comprehensive relief from gastrointestinal disorders. This dual-action medication represents a significant advancement in the management of acid-related digestive conditions and motility disorders. By combining a proton pump inhibitor with a prokinetic agent, ESMOSTRUM IT addresses both the underlying causes and symptomatic manifestations of various digestive ailments, offering patients a complete therapeutic solution in a single, convenient dosage form.\nThe synergistic combination of Esomeprazole and Itopride makes ESMOSTRUM IT particularly effective for individuals suffering from gastroesophageal reflux disease (GERD), functional dyspepsia, and other conditions where both excessive acid production and impaired gastric motility contribute to discomfort and disease progression.\nActive Pharmaceutical Ingredients\nEsomeprazole\nEsomeprazole is the S-isomer of omeprazole and belongs to the class of medications known as proton pump inhibitors (PPIs). It works by specifically and irreversibly blocking the hydrogen-potassium adenosine triphosphatase enzyme system (the proton pump) located in the gastric parietal cells. This mechanism effectively reduces gastric acid secretion, providing sustained relief from acid-related symptoms and allowing damaged esophageal and gastric tissue to heal.\nItopride\nItopride is a prokinetic agent that enhances gastrointestinal motility through a dual mechanism of action. It acts as both a dopamine D2 receptor antagonist and an acetylcholinesterase inhibitor. By blocking dopamine receptors, it removes the inhibitory effect of dopamine on gastrointestinal motility, while its acetylcholinesterase inhibition increases acetylcholine levels, further promoting coordinated gastric contractions and improved gastric emptying.\nTherapeutic Uses and Indications\nESMOSTRUM IT is prescribed for a wide range of gastrointestinal conditions where both acid suppression and enhanced motility are therapeutically beneficial:\nGastroesophageal Reflux Disease (GERD)\nESMOSTRUM IT provides exceptional relief for patients suffering from GERD, a chronic condition where stomach acid frequently flows back into the esophagus. The esomeprazole component reduces acid production, while itopride improves the tone of the lower esophageal sphincter and accelerates gastric emptying, thereby reducing the frequency and severity of reflux episodes.\nFunctional Dyspepsia\nFor patients experiencing persistent or recurrent upper abdominal discomfort without an identifiable organic cause, ESMOSTRUM IT addresses multiple pathophysiological mechanisms. It relieves symptoms such as early satiety, postprandial fullness, epigastric pain, and bloating by normalizing gastric acid levels and improving gastric accommodation and emptying.\nPeptic Ulcer Disease\nESMOSTRUM IT aids in the healing of gastric and duodenal ulcers by creating an optimal healing environment through sustained acid suppression. The prokinetic action of itopride helps prevent stasis of gastric contents, which can exacerbate ulcer symptoms.\nNon-Ulcer Dyspepsia\nMany patients experience dyspeptic symptoms without evidence of ulceration. ESMOSTRUM IT effectively manages these symptoms by addressing both acid hypersecretion and delayed gastric emptying, two key factors in non-ulcer dyspepsia.\nGastroparesis-Related Symptoms\nIn conditions where gastric emptying is significantly delayed, the itopride component of ESMOSTRUM IT helps restore more normal gastric motility patterns, reducing associated symptoms like nausea, vomiting, and abdominal distension.\nKey Benefits and Advantages\nDual Mechanism of Action\nThe primary advantage of ESMOSTRUM IT lies in its comprehensive approach to gastrointestinal health. Rather than addressing only acid production or motility in isolation, this combination therapy tackles both aspects simultaneously, providing more complete symptom relief and better therapeutic outcomes.\nSuperior Acid Suppression\nEsomeprazole offers more consistent and prolonged acid suppression compared to many other acid-reducing medications. It provides sustained relief throughout the day and night, allowing patients to experience fewer breakthrough symptoms and better quality of life.\nEnhanced Gastric Motility\nThe itopride component specifically targets motility issues without crossing the blood-brain barrier significantly, meaning it provides prokinetic benefits with minimal central nervous system side effects. This results in improved gastric emptying, reduced bloating, and decreased feelings of fullness after meals.\nRapid Symptom Relief\nMany patients experience noticeable improvement in their symptoms within the first few days of treatment with ESMOSTRUM IT. The combination therapy addresses multiple symptom pathways simultaneously, leading to faster and more comprehensive relief.\nImproved Quality of Life\nBy effectively managing symptoms such as heartburn, regurgitation, nausea, bloating, and early satiety, ESMOSTRUM IT significantly enhances patients' daily functioning and overall well-being. Patients report better sleep quality, improved dietary tolerance, and reduced anxiety related to their digestive symptoms.\nConvenient Dosing\nThe combination of two active ingredients in a single formulation improves medication adherence by reducing pill burden. Patients appreciate the simplicity of taking one medication instead of multiple separate preparations.\nMucosal Healing Properties\nBeyond symptom relief, ESMOSTRUM IT promotes actual healing of damaged esophageal and gastric mucosa. The reduced acid environment created by esomeprazole allows inflamed and eroded tissue to regenerate properly.\nReduced Risk of Complications\nBy effectively controlling acid reflux and improving gastric emptying, ESMOSTRUM IT helps prevent potential complications of chronic GERD, such as esophageal strictures, Barrett's esophagus, and respiratory complications from aspiration.\nDosage and Administration\nESMOSTRUM IT should be taken exactly as prescribed by a healthcare professional. Typically, the medication is administered orally, preferably before meals to optimize its therapeutic effects. The standard dosing regimen usually involves once or twice daily administration, though individual requirements may vary based on the severity of the condition and patient response.\nThe medication should be swallowed whole with water and should not be crushed, chewed, or split, as this may affect the drug's release mechanism and therapeutic efficacy. Patients should maintain regular dosing schedules to ensure optimal acid suppression and motility enhancement throughout the day.\nSide Effects and Safety Considerations\nLike all medications, ESMOSTRUM IT may cause side effects in some individuals, though not everyone experiences them. Understanding potential adverse effects helps patients identify and report concerning symptoms promptly.\nCommon Side Effects\nGastrointestinal Effects: Some patients may experience diarrhea, constipation, abdominal pain, nausea, or flatulence, particularly during initial treatment. These effects are usually mild and often resolve as the body adjusts to the medication.\nHeadache: Mild to moderate headaches occur in a small percentage of patients and typically diminish with continued use.\nDizziness: Some individuals may experience lightheadedness or dizziness, particularly when standing up quickly.\nDry Mouth: Reduced saliva production may occur, leading to oral dryness and discomfort.\nLess Common Side Effects\nSkin Reactions: Rash, itching, or other dermatological manifestations may develop in sensitive individuals.\nSleep Disturbances: Some patients report insomnia or unusual dreams while taking the medication.\nIncreased Prolactin Levels: Itopride may cause mild elevation in prolactin levels, though clinical manifestations are rare.\nTaste Alterations: Changes in taste perception or metallic taste may occur temporarily.\nSerious Side Effects (Rare)\nWhile uncommon, certain serious adverse effects require immediate medical attention:\n\nSevere allergic reactions including difficulty breathing, facial swelling, or severe skin reactions\nSevere diarrhea that persists or contains blood\nIrregular heartbeat or palpitations\nMuscle weakness or pain\nSeizures or tremors\nSigns of liver problems including jaundice, dark urine, or persistent nausea\n\nLong-Term Considerations\nExtended use of proton pump inhibitors like esomeprazole has been associated with certain risks that patients should discuss with their healthcare providers:\n\nPotential reduction in calcium, magnesium, and vitamin B12 absorption\nSlightly increased risk of bone fractures with prolonged use\nPossible increased susceptibility to certain gastrointestinal infections\nRare cases of kidney problems\n\nRegular monitoring and periodic assessment by healthcare professionals help minimize these risks while maintaining therapeutic benefits.\nPrecautions and Contraindications\nPatients should inform their healthcare provider about all existing medical conditions, particularly liver disease, kidney problems, osteoporosis, low magnesium levels, or any gastrointestinal bleeding. ESMOSTRUM IT may interact with certain medications, including blood thinners, antifungals, HIV medications, and certain antibiotics. A complete medication review ensures safe and effective therapy.\nPregnant or breastfeeding women should only use ESMOSTRUM IT under strict medical supervision, as the safety profile in these populations requires careful consideration of potential risks and benefits.\nLifestyle Recommendations\nFor optimal therapeutic outcomes, patients taking ESMOSTRUM IT should complement their medication regimen with appropriate lifestyle modifications:\n\nAvoid trigger foods that exacerbate acid reflux, such as spicy foods, citrus, chocolate, caffeine, and alcohol\nMaintain a healthy body weight to reduce abdominal pressure\nEat smaller, more frequent meals rather than large portions\nAvoid lying down immediately after eating; wait at least two to three hours\nElevate the head of the bed if nighttime symptoms occur\nQuit smoking, as tobacco use significantly worsens reflux symptoms\nManage stress through relaxation techniques, as stress can exacerbate digestive symptoms\n\nConclusion\nESMOSTRUM IT represents a sophisticated and effective pharmaceutical solution for individuals struggling with complex gastrointestinal disorders involving both acid hypersecretion and impaired motility. By combining the powerful acid-suppressing capabilities of esomeprazole with the prokinetic benefits of itopride, this medication offers comprehensive symptom management that addresses the multifaceted nature of digestive disorders.", "price": 182.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2273, "imageuri": "https://productimages.withfloats.com/actual/69623e6fd8491171373812e3.png", "tileimageuri": "https://productimages.withfloats.com/tile/69623e6fd8491171373812e3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-10T11:56:28.061Z", "updatedon": "2026-01-17T05:39:38.96Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/esomeprazole-and-itopride/2273", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ESMOSTRUM IT", "category": "GASTROLOGYRANGE", "tags": [ "esomeprazole and itopride tablets", "esomeprazole itopride combination tablet", "esomeprazole with itopride capsules", "esomeprazole itopride medicine uses", "esomeprazole itopride dosage", "what is esomeprazole and itopride used for", "esomeprazole and itopride combination meaning", "how esomeprazole and itopride work together", "benefits of esomeprazole and itopride tablets", "esomeprazole itopride for acidity and gas", "esomeprazole and itopride for acid reflux", "esomeprazole and itopride tablets price", "esomeprazole itopride tablets price in india", "best brand of esomeprazole and itopride", "esomeprazole itopride tablets manufacturers", "can esomeprazole and itopride be taken together", "is esomeprazole and itopride safe", "how long to take esomeprazole itopride" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694cf85408591c1173b54c2f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Pregabalin Epalrestat and Methylcobalamin Tablets", "description": "EPSTATE ED represents an advanced pharmaceutical formulation that combines three powerful therapeutic agents: Pregabalin, Epalrestat, and Methylcobalamin. This innovative triple-combination medication is specifically designed to address the complex pathophysiology of diabetic neuropathy and neuropathic pain conditions. By integrating multiple mechanisms of action, EPSTATE ED offers a comprehensive approach to managing nerve-related complications that significantly impact the quality of life for millions of individuals worldwide.\nThe formulation addresses not only the symptomatic relief of neuropathic pain but also targets the underlying metabolic derangements that contribute to nerve damage progression. This multi-pronged therapeutic strategy makes EPSTATE ED particularly valuable for patients who require more than symptomatic management alone.\nUnderstanding the Active Components\nPregabalin: The Neuropathic Pain Modulator\nPregabalin serves as the cornerstone analgesic component in EPSTATE ED. This anticonvulsant medication works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. Through this mechanism, Pregabalin reduces the release of excitatory neurotransmitters including glutamate, norepinephrine, and substance P. This reduction in neurotransmitter release effectively dampens the abnormal neural signaling that characterizes neuropathic pain conditions.\nThe molecule demonstrates excellent bioavailability and rapid absorption, allowing patients to experience relief within a relatively short timeframe. Its efficacy in managing various neuropathic pain syndromes has been extensively documented in clinical trials, establishing it as a first-line agent for diabetic peripheral neuropathy, postherpetic neuralgia, and other chronic neuropathic pain conditions.\nEpalrestat: The Aldose Reductase Inhibitor\nEpalrestat represents a unique addition to the formulation, functioning as a selective aldose reductase inhibitor. In diabetic conditions, excess glucose is converted to sorbitol through the polyol pathway, with aldose reductase serving as the rate-limiting enzyme. The accumulation of sorbitol within nerve cells leads to osmotic stress, depletion of myoinositol, and subsequent nerve dysfunction.\nBy inhibiting aldose reductase, Epalrestat prevents this harmful sorbitol accumulation, thereby addressing one of the fundamental metabolic abnormalities responsible for diabetic neuropathy. This disease-modifying approach distinguishes EPSTATE ED from purely symptomatic treatments. Epalrestat has been particularly well-studied in Asian populations and has demonstrated the ability to improve nerve conduction velocities and reduce subjective neuropathic symptoms over time.\nMethylcobalamin: The Neurotropic Vitamin\nMethylcobalamin, the bioactive form of Vitamin B12, completes the therapeutic triad in EPSTATE ED. Unlike cyanocobalamin, which requires conversion in the body, methylcobalamin is immediately available for utilization in crucial biochemical processes. It plays an indispensable role in myelin synthesis, the protective sheath surrounding nerve fibers that enables proper signal transmission.\nThis coenzyme participates in methionine synthesis and is essential for maintaining the structural and functional integrity of neurons. Methylcobalamin also facilitates nerve regeneration and has demonstrated neuroprotective properties in various experimental models. For patients with diabetic neuropathy, who often exhibit Vitamin B12 deficiency (sometimes exacerbated by metformin therapy), supplementation with methylcobalamin addresses both nutritional deficits and supports nerve health at a fundamental level.\nClinical Applications and Uses\nEPSTATE ED is primarily indicated for the comprehensive management of diabetic peripheral neuropathy, a condition affecting approximately 50% of individuals with long-standing diabetes. The symptoms of this condition range from tingling sensations and burning pain to numbness and loss of protective sensation, which can lead to serious complications including foot ulcers and amputations.\nBeyond diabetic neuropathy, EPSTATE ED may be prescribed for various neuropathic pain syndromes where the combination of pain relief, metabolic correction, and nerve support proves beneficial. Patients experiencing chronic nerve pain resulting from metabolic disturbances, nutritional deficiencies, or structural nerve damage may find this combination particularly effective.\nThe medication is typically recommended for adults who have not achieved adequate symptom control with single-agent therapy or who would benefit from the synergistic effects of the three components. Healthcare providers may prescribe EPSTATE ED when a patient requires both immediate symptom relief and long-term disease modification.\nKey Benefits and Therapeutic Advantages\nComprehensive Multi-Mechanism Action\nThe primary advantage of EPSTATE ED lies in its multi-faceted approach to neuropathic conditions. Rather than addressing only pain symptoms, the formulation simultaneously tackles pain perception, underlying metabolic abnormalities, and nutritional support for nerve health. This comprehensive strategy may lead to superior outcomes compared to monotherapy approaches.\nEnhanced Pain Relief\nClinical evidence supporting Pregabalin's efficacy in neuropathic pain is substantial. Patients often report significant reductions in pain intensity, improved sleep quality due to decreased nocturnal pain, and enhanced ability to perform daily activities. The pain-relieving effects typically manifest within the first week of therapy and continue to improve with ongoing treatment.\nDisease Modification Potential\nUnlike purely symptomatic treatments, the inclusion of Epalrestat provides genuine disease-modifying potential. By targeting the polyol pathway, EPSTATE ED may slow the progression of nerve damage in diabetic patients. Long-term use may preserve nerve function and prevent the worsening of neuropathic symptoms, offering hope beyond mere symptom management.\nImproved Nerve Conduction and Function\nThe combination of metabolic correction through Epalrestat and neurotropic support via Methylcobalamin creates an environment conducive to nerve regeneration and functional improvement. Studies have demonstrated improvements in nerve conduction velocity parameters with similar combination therapies, suggesting potential restoration of nerve function rather than simple symptom masking.\nConvenience of Combination Therapy\nFor patients who would otherwise require multiple separate medications, EPSTATE ED offers the convenience of a single tablet containing all three therapeutic agents. This simplification of medication regimens improves compliance, reduces pill burden, and may enhance overall treatment outcomes.\nQuality of Life Enhancement\nThe cumulative effect of pain reduction, improved nerve function, and better metabolic control translates into meaningful quality of life improvements. Patients report better mobility, reduced interference of pain with daily activities, improved mood, and enhanced social functioning.\nPotential Side Effects and Safety Considerations\nCommon Side Effects\nAs with any pharmaceutical agent, EPSTATE ED may produce certain adverse effects. The most commonly reported side effects are primarily attributable to the Pregabalin component and include dizziness, somnolence, peripheral edema, dry mouth, blurred vision, weight gain, and difficulty with concentration or attention. These effects are generally mild to moderate and often diminish with continued therapy as the body adapts to the medication.\nGastrointestinal symptoms such as constipation or nausea may occur, though they are typically manageable with dietary modifications or symptomatic treatment. Some patients experience increased appetite leading to weight gain, which requires monitoring, particularly in diabetic individuals where weight management is crucial.\nSerious but Rare Adverse Events\nThough uncommon, certain serious adverse effects warrant immediate medical attention. These include allergic reactions manifesting as rash, itching, swelling, severe dizziness, or breathing difficulties. Pregabalin has been associated with rare cases of angioedema, which requires prompt discontinuation and medical intervention.\nMental health changes, including mood alterations, anxiety, depression, agitation, or suicidal thoughts, have been reported with Pregabalin use, particularly in individuals with pre-existing psychiatric conditions. Patients and caregivers should remain vigilant for behavioral changes and report them immediately to healthcare providers.\nDrug Interactions and Precautions\nEPSTATE ED may interact with other central nervous system depressants, including alcohol, opioids, benzodiazepines, and antihistamines, potentially intensifying sedation and cognitive impairment. Patients should inform their healthcare provider of all medications, supplements, and substances they consume.\nIndividuals with kidney impairment require dose adjustments since Pregabalin is primarily eliminated through renal excretion. Regular monitoring of renal function may be necessary during long-term therapy.\nSpecial Population Considerations\nPregnant or breastfeeding women should use EPSTATE ED only when clearly necessary and under strict medical supervision, as the safety profile in these populations has not been fully established. Elderly patients may be more susceptible to side effects, particularly dizziness and confusion, necessitating careful dose titration and monitoring.\nPatients should be advised against abrupt discontinuation of EPSTATE ED, as sudden cessation of Pregabalin may precipitate withdrawal symptoms including insomnia, nausea, headache, anxiety, and sweating. Gradual dose reduction under medical supervision is recommended when discontinuing therapy.\nDosage and Administration Guidelines\nThe appropriate dosage of EPSTATE ED is highly individualized and should be determined by a qualified healthcare professional based on the patient's specific condition, response to therapy, and tolerance. Typically, treatment begins with a lower dose that is gradually increased to achieve optimal therapeutic benefit while minimizing adverse effects.\nPatients should take EPSTATE ED exactly as prescribed, with or without food, at consistent times each day to maintain stable blood levels. Missing doses should be addressed by taking the forgotten dose as soon as remembered, unless it's nearly time for the next scheduled dose. Double dosing to compensate for missed doses is not recommended.\nRegular follow-up appointments allow healthcare providers to assess treatment efficacy, monitor for adverse effects, and make necessary dose adjustments. Patients should maintain open communication with their medical team regarding symptom improvement, side effects, and any concerns that arise during therapy.\nPatient Counseling and Lifestyle Recommendations\nMaximizing the benefits of EPSTATE ED extends beyond simply taking the medication. Patients should be counseled on complementary lifestyle measures that support neuropathy management. Maintaining optimal glycemic control remains paramount for diabetic patients, as blood sugar management directly impacts neuropathy progression regardless of medication.\nRegular physical activity, within individual capabilities, promotes circulation, supports nerve health, and may enhance the therapeutic effects of EPSTATE ED. Daily foot examinations become critical for diabetic patients to identify potential injuries early, preventing serious complications.\nNutritional optimization, including adequate intake of B vitamins, antioxidants, and essential nutrients, supports the neurotropic effects of Methylcobalamin. Avoiding alcohol and tobacco, both of which can exacerbate neuropathy, is strongly recommended.\nPatients should be cautioned about activities requiring alertness, such as driving or operating machinery, especially during the initial treatment phase when dizziness and somnolence may be more pronounced. These effects typically improve with continued therapy, but individual responses vary.\nConclusion\nEPSTATE ED represents a thoughtfully designed pharmaceutical formulation that addresses the multifaceted nature of diabetic neuropathy and neuropathic pain through its unique combination of Pregabalin, Epalrestat, and Methylcobalamin. This triple-action approach offers patients more than symptomatic relief—it provides genuine disease modification potential, nutritional support, and comprehensive nerve health optimization.\nThe synergistic effects of these three components create a therapeutic profile that is greater than the sum of its parts. While Pregabalin efficiently manages pain symptoms and improves quality of life in the short term, Epalrestat works to address underlying metabolic derangements that drive disease progression, and Methylcobalamin provides essential neurotropic support for nerve regeneration and function.\nFor patients struggling with the debilitating effects of neuropathic pain and diabetic neuropathy, EPSTATE ED offers renewed hope for better symptom control and potentially slowed disease progression. The convenience of combination therapy in a single tablet improves adherence and simplifies complex treatment regimens.\nHowever, EPSTATE ED is not without considerations. Potential side effects, though generally manageable, require awareness and monitoring. The medication is most effective when integrated into a comprehensive management plan that includes optimal glycemic control, lifestyle modifications, and regular medical supervision.\nUltimately, EPSTATE ED should be viewed as a valuable tool in the therapeutic arsenal against neuropathic conditions, best utilized under the guidance of knowledgeable healthcare professionals who can individualize treatment to each patient's unique needs and circumstances. With proper use, monitoring, and patient education, EPSTATE ED can significantly improve outcomes and quality of life for those affected by these challenging neurological conditions.", "price": 275.0, "discountamount": 82.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2253, "imageuri": "https://productimages.withfloats.com/actual/694cf859d25fa0b0657b1ac8.png", "tileimageuri": "https://productimages.withfloats.com/tile/694cf859d25fa0b0657b1ac8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-25T08:39:48.947Z", "updatedon": "2026-01-10T06:06:36.677Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pregabalin-epalrestat-and-methylcobalamin-tablets/2253", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EPSTATE ED", "category": "NEUROLOGYRANGE", "tags": [ "regabalin, Epalrestat, and Methylcobalamin.neuropathic pain conditions.", "Pregabalin, Epalrestat, and Methylcobalamin.", "neuropathic pain.", "diabetic neuropathy.", "sorbitol within nerve cells leads to osmotic stress.", "Epalrestat and neurotropic support via Methylcobalamin creates an environment .", "mood alterations, anxiety, depression, agitation.", "supports the neurotropic effects of Methylcobalamin." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694919f0de5d3e57a93413a8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "elagolix 150mg tablet", "description": "Eligolux 150 delivers 150mg of elagolix per tablet, formulated as an oral, once-daily option in convenient packs for ongoing therapy. As a non-peptide GnRH receptor antagonist, it selectively suppresses pituitary gonadotropins, reducing ovarian estrogen production without the flare effect of agonists. Ideal for patients with milder symptoms or those prioritizing bone health, this dose minimizes hypoestrogenic risks while targeting endometriotic pain.\n\nTake Eligolux 150 whole with water, with or without food, preferably at the same time daily. Storage requires a cool, dry environment below 30°C, away from children and moisture. Steris Healthcare ensures GMP-compliant manufacturing, making it accessible across India for endometriosis care.\n\nPrimary Uses and Indications\nEligolux 150 primarily treats moderate endometriosis-associated pain, including dysmenorrhea, chronic pelvic discomfort, and dyspareunia. Endometriosis impacts 10% of reproductive-age women, causing ectopic endometrial growth that triggers inflammation and scarring; elagolix 150mg curbs estrogen-driven progression.\n​\nPrescribed when NSAIDs or combined pills prove inadequate, it excels in non-severe cases, allowing prolonged use. Emerging evidence supports its role in heavy menstrual bleeding from fibroids, though primary approval focuses on pain relief. Start therapy within the first week of menses for optimal synchronization.\n​\nMechanism of Action\nElagolix in Eligolux 150 competitively binds GnRH receptors, dose-dependently inhibiting LH/FSH release. This lowers estradiol by 40-60%—less aggressive than 200mg—halting endometrial tissue proliferation outside the uterus. Peak levels hit in 1 hour, with a 4-6 hour half-life supporting steady-state suppression on QD dosing.\n​\nUnlike agonists, no initial hormone surge occurs, preventing worsened pain. Partial estrogen reduction preserves some bone-protective effects, differentiating it from deeper suppression therapies.\n\nKey Benefits\nEligolux 150 shines in clinical responsiveness: phase 3 trials showed 32% dysmenorrhea resolution versus 20% placebo at 6 months, with 50% pain score drops. Quality-of-life gains include better work attendance, sleep, and relationships, per EQ-5D assessments.\n​\nExtended 24-month approval suits long-term control, with amenorrhea in 40-50% of users reducing bleeding volume by 70%. Oral ease beats injectables, enhancing adherence at 85% in studies. Lower BMD impact (0.5-1% loss/year) allows safer continuation versus higher doses.\n\nBenefit\tTrial Data\tPatient Impact\nPain Reduction\t32-50% dysmenorrhea-free \n​\tDaily activity restoration\nBleeding Control\t70% volume drop \n​\tAnemia prevention\nLong-Term Use:\tUp to 24 months \n​\tSustained relief\nQoL Improvement\tEQ-5D gains \n​\tEmotional well-being\nPotential Side Effects\nVasomotor symptoms dominate: hot flashes (20-30%), headaches (17%), and night sweats (10-15%) emerge early but fade. Nausea (8%), insomnia (7%), and mild depression (5%) affect minorities, with a 70% event rate mostly grade 1.\n​\nBMD decline averages -0.9% at the spine after 12 months, monitored via DEXA. Discontinuation hovers at 5-8%.\n\nSide Effect\tIncidence\tMitigation\nHot Flashes\t20-30% \n​\tVentilation, timing\nHeadache\t17% \n​\tAnalgesics\nBMD Loss\t0.9% \n​\tSupplements, scans\nMood Shifts\t5% \n​\tMonitoring\nSerious Risks and Management\nSuicidality (0.1-0.5%) demands baseline psych screening; halt if worsening. Liver enzymes rise in 1%, requiring LFTs at 3/6 months. Rare anaphylaxis or thromboembolism prompts immediate cessation. Avoid in osteoporosis or smokers >35.\n​\n\nDosage Guidelines\n150 mg once daily for up to 24 months in normal/mild liver function; limit to 6 months in moderate impairment (Child-Pugh B). No titration needed; miss a dose? Resume the next day, no doubling. Pair with 1 g calcium/800 IU vitamin D daily.\n​\n\nPrecautions and Contraindications\nPregnancy category X: mandates non-hormonal birth control during and 1 week post-therapy. Screen hepatic/renal function; avoid severe cases. CYP3A interactions (e.g., rifampin reduces efficacy) need dose review. Breastfeeding is contraindicated.\n​\nClinical Evidence and Efficacy\nElaris trials (n=1,689) confirmed superiority: co-primary endpoints met with 75% responder rates for pain. 12-month extensions showed persistent efficacy and low rebound. Versus 200mg, 150mg balances tolerability for moderate pain.\n​\nConclusion\nEligolux 150 empowers women with moderate endometriosis pain through precise, extended hormonal modulation and proven outcomes. Regular physician oversight maximizes safety and efficacy.\n", "price": 700.0, "discountamount": 210.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2252, "imageuri": "https://productimages.withfloats.com/actual/694a2af01e4092f757d90bb5.png", "tileimageuri": "https://productimages.withfloats.com/tile/694a2af01e4092f757d90bb5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T10:14:08.773Z", "updatedon": "2026-01-09T05:31:32.372Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/elagolix-150mg-tablet/2252", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 150", "category": "Gynaecology", "tags": [ "elagolix 150mg tablet", "prioritizing bone health.", "endometriotic pain.", "endometrial tissue proliferation outside the uterus.", "Eligolux 150 empowers women with moderate endometriosis pain through precise.", "hormonal modulation and proven outcomes.", "gonadotropins.", "endometriotic pain." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6948e738796e72bd2659934b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "micronized purified flavonoid fraction", "description": "Product Name: FLAVOSHIELD 500\nActive Ingredients: Micronized Purified Flavonoid Fraction (MPFF) 500mg, containing Diosmin 450mg and Hesperidin 50mg.\nPresentation: Oral Tablets\n\nUnveiling FLAVOSHIELD 500: A Deep Dive into Advanced Venous and Vascular Wellness\nIn the intricate network of the human circulatory system, veins perform the silent, relentless task of returning blood to the heart against gravity. When this system faces strain, it can manifest through discomfort, heaviness, and visible changes that impact both physical well-being and quality of life. Enter FLAVOSHIELD 500, a sophisticated pharmaceutical-grade formulation designed to fortify venous health at its core. Powered by a Micronized Purified Flavonoid Fraction (MPFF)—a precise blend of 450mg Diosmin and 50mg Hesperidin—FLAVOSHIELD 500 represents a pinnacle in venoactive therapy. This comprehensive description explores the product, its mechanism, multifaceted uses, key benefits, safety profile, and its role in a holistic health strategy.\n\nWhat is FLAVOSHIELD 500? The Science of MPFF\nFLAVOSHIELD 500 is not a simple herbal supplement; it is a clinically researched, standardized medical treatment. Its active core, the Micronized Purified Flavonoid Fraction, is derived from citrus fruits but undergoes a specialized purification and micronization process. This technological advancement is crucial:\n\nPurification: Ensures a consistent, high-potency concentration of the active flavonoid molecules, Diosmin and Hesperidin, free from plant impurities.\nMicronization: Reduces the particle size of the flavonoids dramatically, increasing their surface area. This leads to significantly enhanced absorption in the gastrointestinal tract, ensuring that a much higher percentage of the active dose reaches the bloodstream and, ultimately, the target venous tissues. Compared to non-micronized diosmin, MPFF offers up to 30% greater bioavailability, making FLAVOSHIELD 500 a more effective and reliable choice.\nThis synergy of Diosmin and Hesperidin works on multiple physiological pathways to restore venous tone and capillary integrity.\n\nPrimary Uses and Therapeutic Applications\nFLAVOSHIELD 500 is indicated for the management of various stages of chronic venous disorders and related conditions:\n\nChronic Venous Disease (CVD) & Venous Insufficiency: This is the primary use. It alleviates the distressing symptoms stemming from weakened vein walls and faulty valves in the legs. These include:\n\nHeaviness and Fatigue: The pervasive feeling of weight and tiredness in the legs, especially after prolonged standing or sitting.\nPain and Aching: Dull, throbbing, or cramping pain that improves with elevation.\nSwelling (Edema): Reduction of ankle and lower leg swelling caused by fluid leakage from capillaries.\nNocturnal Cramps: Relief from painful muscle spasms that often occur at night.\nHemorrhoidal Disease (Acute and Chronic): MPFF is a cornerstone in hemorrhoid management. It treats acute hemorrhoidal attacks by reducing bleeding, pain, and discharge. For chronic cases, it helps prevent recurrences by decreasing capillary fragility and inflammation in the anal venous plexus.\n\nPost-Phlebitic Syndrome: Following deep vein thrombosis (DVT), patients often suffer from chronic leg swelling, pain, and skin changes. FLAVOSHIELD 500 can be part of the management plan to improve microcirculation and reduce symptoms.\n\nSupport Post-Sclerotherapy or Surgical Procedures: It is commonly used after vein stripping, laser ablation, or sclerotherapy to support healing, reduce postoperative swelling and bruising, and help consolidate results.\n\nKey Benefits and Mechanism of Action: The Multi-Target Approach\nThe efficacy of FLAVOSHIELD 500 stems from its multi-faceted pharmacological actions on the venous and lymphatic systems:\n\nVenotonic Action: It increases venous tone and elasticity by promoting the contraction of smooth muscle in the vein walls. This helps veins propel blood more efficiently upward, reducing pooling and pressure. Think of it as “tightening” slackened venous structures.\n\nCapillary-Protective & Anti-Inflammatory Effects: It strengthens capillary walls (reduces capillary permeability) and inhibits the release of inflammatory mediators (like prostaglandins and leukotrienes). This dual action minimizes the leakage of fluid, proteins, and inflammatory cells into surrounding tissues, thereby directly addressing edema (swelling) and inflammation. This is particularly vital in hemorrhoidal tissue.\n\nLymphatic Enhancement: FLAVOSHIELD 500 has been shown to increase lymphatic drainage by boosting the frequency and intensity of lymphatic contractions. This provides an additional route for removing excess interstitial fluid and proteins, further reducing swelling.\n\nAntioxidant Activity: The flavonoids scavenge harmful free radicals, protecting venous and capillary endothelial cells from oxidative stress, which is a contributing factor in chronic venous disease.\n\nImprovement of Microcirculation: By reducing blood viscosity and inhibiting red blood cell aggregation, it improves blood flow in the smallest vessels, enhancing oxygen delivery and waste removal at the tissue level.\n\nPatient-Centric Benefits:\n\nRapid Symptom Relief: Patients often report a noticeable decrease in leg heaviness and pain within the first few weeks of treatment.\nEnhanced Quality of Life: Restores the ability to stand, walk, and engage in daily activities with greater comfort and less discomfort.\nReduced Reliance on Pain Medication: By addressing the underlying inflammation and pain of venous issues and hemorrhoids, it can decrease the need for NSAIDs.\nComplement to Compression Therapy: Works synergistically with compression stockings, often allowing for better tolerance and compliance with compression wear.\nSide Effects and Safety Profile: What to Expect\nFLAVOSHIELD 500 is generally very well-tolerated, with a low incidence of side effects, which are typically mild and transient. This excellent safety profile is a result of its natural origin and high purification.\n\nCommon Side Effects (Rare and usually mild):\n\nGastrointestinal: Some individuals may experience mild, transient digestive disturbances such as nausea, stomach pain, diarrhea, or heartburn. Taking the tablet with a meal can often mitigate this.\nNeurological: Occasional reports of headache or dizziness.\nAllergic Reactions: Very rare cases of skin rash or itching have been reported.\nImportant Safety Considerations:\n\nPregnancy and Lactation: While no teratogenic effects have been demonstrated, as a precaution, use during pregnancy (especially the first trimester) and breastfeeding should only be under the direct supervision of a physician who has weighed the benefits against potential risks.\nDrug Interactions: No significant pharmacokinetic drug interactions have been formally reported. However, as with any medication, it is prudent to inform your doctor about all other medicines and supplements you are taking.\nContraindications: Hypersensitivity to any of the components (Diosmin, Hesperidin, or excipients in the tablet) is a contraindication.\nCrucial Note: FLAVOSHIELD 500 is a treatment for symptoms and a stabilizer of venous function, not a cure for underlying venous valve incompetence. It does not replace definitive interventional treatments (like ablation or surgery) for advanced varicose veins when they are medically indicated. It is essential to receive a proper diagnosis from a healthcare professional to rule out other causes of leg swelling or pain (e.g., cardiac, renal, or hepatic origin).\n\nConclusion: FLAVOSHIELD 500 – A Cornerstone of Comprehensive Venous Care\nIn conclusion, FLAVOSHIELD 500 stands as a robust, scientifically validated agent in the realm of vascular health. Its advanced MPFF technology, combining 450mg of micronized Diosmin with 50mg of Hesperidin, delivers enhanced bioavailability and a powerful, multi-target action that addresses the root causes of venous discomfort: poor tone, capillary fragility, inflammation, and impaired lymphatic drainage.\n\nWhether battling the daily fatigue of heavy legs, managing the acute distress of a hemorrhoidal flare-up, or supporting recovery after a venous procedure, FLAVOSHIELD 500 offers a reliable and well-tolerated therapeutic option. Its benefits in improving symptoms and quality of life are clear, backed by a strong body of clinical evidence.\n\nHowever, optimal venous health is a holistic endeavor. FLAVOSHIELD 500 should be viewed as the pharmacological cornerstone of a broader management plan. This plan should include:\n\nMedical Supervision: Regular consultation with a vascular specialist or phlebologist.\nLifestyle Modifications: Weight management, regular low-impact exercise (walking, swimming), and elevation of the legs.\nCompression Therapy: The use of medically prescribed compression stockings when recommended.\nDietary Awareness: A fiber-rich diet to prevent constipation and straining.\nBy integrating FLAVOSHIELD 500 into this comprehensive approach, individuals can take proactive control of their venous health, shielding their vitality and comfort from the burdens of venous insufficiency. Always consult your healthcare provider to determine if FLAVOSHIELD 500 is appropriate for your specific condition and to establish the correct dosage and treatment duration.\n\nDisclaimer: This content is for informational purposes only and does not constitute medical advice. Always seek the guidance of a qualified healthcare professional with any questions regarding a medical condition or treatment. Do not delay seeking or disregard professional medical advice based on information contained here.", "price": 218.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2250, "imageuri": "https://productimages.withfloats.com/actual/6948e7392f14bd83555d1409.png", "tileimageuri": "https://productimages.withfloats.com/tile/6948e7392f14bd83555d1409.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T06:37:44.038Z", "updatedon": "2026-02-20T06:30:16.4Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/micronized-purified-flavonoid-fraction/2250", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "FLAVOSHIELD 500", "category": "GENERAL RANGE", "tags": [ "A Deep Dive into Advanced Venous and Vascular Wellness", "human circulatory system", "blood to the heart against gravity.", "Powered by a Micronized Purified Flavonoid Fraction (MPFF)", "Hemorrhoidal Disease", "By reducing blood viscosity and inhibiting red blood cell aggregation", "holistic health strategy.", "Chronic Venous Insufficiency (CVI)", "Varicose Veins", "Hemorrhoids (Piles)", "Venous Ulcers", "Lymphedema", "Post-Surgical Venous Recovery", "micronized purified flavonoid fraction.", "micronized purified flavonoid fraction 500 mg tablet.", "micronized purified flavonoid fraction 1000 mg uses.", "micronized purified flavonoid fraction tablet uses.", "micronized purified flavonoid fraction uses in hindi", "micronized purified flavonoid fraction uses.", "tab micronized purified flavonoid fraction.", "micronized purified flavonoid fraction side effects.", "micronized purified flavonoid fraction 500 mg." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68c29ba02244c906e7790e2b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "tenofovir disoproxil fumarate tablets 300 mg", "description": "TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function.\n\nTenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications.\nKey Indications:\n\nTELAVINCE 300 is indicated for:\nHIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg).\nChronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication.\n\n \nMechanism of Action:\n \nTenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread.\nDosage and Administration:\nRecommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food.\nFor HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen.\n\nFor Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment.\n\nDosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease.\n\nKey Benefits of TELAVINCE 300:\nPotent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication.\nOnce-Daily Dosing: Improves patient compliance and treatment adherence.\nBacked by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count).\nTrusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes.\nPart of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B.\n\n \nSafety and Precautions:\nRenal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment.\nBone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis.\n\nHepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment.\n\nLactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention.\n\nPossible Side Effects:\n\nMost patients tolerate TELAVINCE 300 well. However, some may experience:\n\nNausea\nDiarrhea\nHeadache\nFatigue\nRash\nDizziness\nDecreased bone mineral density\nRenal impairment (in rare cases)\n\nIf any side effects persist or worsen, consult a healthcare professional immediately.\n\n \nStorage Instructions:\n \nStore in a cool, dry place below 30°C.\nProtect from light and moisture.\nKeep out of reach of children.\n\n \n\nWhy Choose TELAVINCE 300?\n \nTELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards.\n\n \nDisclaimer:\n\n\nThis product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.", "price": 1480.0, "discountamount": 444.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2179, "imageuri": "https://productimages.withfloats.com/actual/68c29ba3794abb27ab248d73.png", "tileimageuri": "https://productimages.withfloats.com/tile/68c29ba3794abb27ab248d73.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-11T09:51:28.508Z", "updatedon": "2026-01-12T09:04:54.051Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tenofovir-disoproxil-fumarate-tablets-300-mg/2179", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TELAVINCE 300", "category": "GENERAL RANGE", "tags": [ "Tenofovir Disoproxil Fumarate 300 mg", "HIV-1 infection", "TELAVINCE 300", "Lactic Acidosis and Hepatomegaly", "tenofovir disoproxil fumarate tablets 300 mg", "tenofovir disoproxil fumarate 300 mg tablets", "tenofovir tablets 300 mg uses", "tenofovir disoproxil fumarate tablet ip 300 mg", "tenofovir 300 mg oral tablets", "what is tenofovir disoproxil fumarate 300 mg", "tenofovir disoproxil fumarate tablets uses", "how tenofovir disoproxil fumarate works", "tenofovir 300 mg tablet for hiv treatment", "tenofovir tablets 300 mg for hiv infection", "tenofovir 300 mg antiviral tablet", "tenofovir disoproxil fumarate tablets 300 mg price", "tenofovir 300 mg tablets price in india", "tenofovir disoproxil fumarate tablets supplier", "tenofovir 300 mg tablets manufacturer india", "buy tenofovir disoproxil fumarate tablets 300 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "685bf1b58f1119e73c154485", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "rebamipide alpha lipoic acid and acetylcysteine capsules", "description": "REBAMPEE OTIC is an advanced nutraceutical formulation combining rebamipide, alpha lipoic acid, and acetylcysteine, uniquely designed to support inner ear health and manage age-related hearing loss. The synergistic combination of these three active ingredients works to reduce oxidative stress, prevent cellular degeneration, and support nerve function, offering a targeted solution in cases where oxidative damage contributes to auditory decline. The formulation, known as rebamipide alpha 100mg lipoic acid 100mg and acetylcysteine 100mg capsules, is gaining attention in otolaryngology as a supportive therapy for managing sensorineural and degenerative hearing conditions.\n\nWhat is REBAMPEE OTIC?\nREBAMPEE OTIC is a capsule formulation composed of three clinically significant ingredients:\n\nRebamipide (100 mg): Known for its mucosal protective and antioxidant properties, it plays a role in reducing inflammation and protecting the delicate inner ear structures from oxidative damage.\n\nAlpha Lipoic Acid (100 mg): A powerful antioxidant that supports nerve regeneration and protects against cellular degeneration in the cochlea and auditory pathways.\n\nAcetylcysteine (100 mg): An effective mucolytic and precursor to glutathione, it combats oxidative stress and may help reduce cochlear damage due to noise, drugs, or aging.\n\nTogether, they act to protect and rejuvenate auditory cells, making REBAMPEE OTIC a promising aid in the treatment and management of age-related hearing loss and oxidative stress-induced otological damage.\n\nUses of REBAMPEE OTIC\nUsed in the treatment of age-related hearing loss (presbycusis)\n\nHelps protect auditory nerve cells from oxidative damage\n\nSupports cochlear and inner ear health in degenerative auditory conditions\n\nMay aid in managing hearing impairment due to noise exposure or ototoxic medications\n\nPromotes antioxidant activity and inner ear cellular regeneration\n\nPossible Side Effects\nMost people tolerate REBAMPEE OTIC well, but some may experience mild to moderate side effects such as:\n\nNausea\n\nMild headache\n\nHeartburn\n\nDizziness\n\nAbdominal discomfort\n\nFatigue\n\nSerious Side Effects (Rare)\nIn rare cases, more severe effects may occur:\n\nAllergic reactions such as skin rash, itching, or swelling\n\nSevere abdominal pain\n\nBreathing difficulty or tightness in the chest\n\nSevere dizziness or fainting\n\nHepatic enzyme elevation or liver dysfunction\n\nSeek immediate medical attention if any serious symptoms occur.\n\nPrecautions Before Using REBAMPEE OTIC\nConsult your physician before starting if you have liver disease, kidney dysfunction, or any autoimmune condition\n\nNot recommended during pregnancy or breastfeeding unless prescribed by a doctor\n\nUse with caution in individuals with a known allergy to any of the ingredients\n\nAvoid excessive alcohol consumption during the course as it may increase liver stress\n\nNot to be used as a replacement for medically prescribed treatments for hearing loss without a physician’s recommendation\n\nDrug Interactions\nREBAMPEE OTIC may interact with several medications. It is important to inform your healthcare provider about all drugs you are currently taking, including supplements and herbal products.\n\nWhat drugs interact with REBAMPEE OTIC?\n\nAnticoagulants (e.g., warfarin): Alpha lipoic acid may enhance the anticoagulant effect, increasing the risk of bleeding\n\nAntidiabetic medications: May enhance the glucose-lowering effect, increasing the risk of hypoglycemia\n\nIron supplements: Acetylcysteine may interact with iron metabolism\n\nCertain antibiotics: NAC (acetylcysteine) may reduce the efficacy of some antibiotics if taken simultaneously\n\nThyroid medications: Alpha lipoic acid may interfere with thyroid hormone levels\n\nCisplatin and aminoglycoside antibiotics: When used with antioxidants like NAC, ototoxicity might be reduced, but consult your doctor for adjusted therapy\n\nAlways consult your doctor or pharmacist before combining REBAMPEE OTIC with other medications.\n\nConclusion\nREBAMPEE OTIC is a scientifically developed capsule combining rebamipide, alpha lipoic acid, and acetylcysteine, each known for its distinct cellular protective roles. When used as directed, this formula helps mitigate the effects of age-related hearing loss and supports inner ear health through potent antioxidant action. Safe, effective, and based on evidence-backed ingredients, REBAMPEE OTIC offers new hope for those experiencing the early signs of auditory decline.", "price": 262.0, "discountamount": 79.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "reduce absorption", "rebamipide 100mg", "gastrointestinal issues", "vasodilators caution", "drugs interact", "worsens consult", "liver enzymes", "promote healing", "chronic conditions", "chronic inflammation", "individuals suffering", "lasting relief", "acetylcysteine 100mgtargeting", "wellbalanced combination", "activated charcoal", "respiratory sensitivity", "breastfeeding womenonly", "kidney disorders", "precautions inform", "symptom persists", "side effects", "rare cases", "taste due", "diarrhea headache", "generally welltolerated", "burning sensation", "tingling numbness", "metabolic disorders", "oxidative stress", "ulcers reduction", "gastric mucosa", "diabetic neuropathy", "neurological protection", "oxidative damage", "powerful mucolytic", "universal antioxidant", "multifunctional capsule", "ideal adjunct", "tripleaction formulation", "neuroprotective properties", "antioxidant mucosalprotective", "cellular health", "mucosal protection", "nerve health", "healthcare provider", "medications antacids", "antioxidant agent", "rebampee otic", "starting rebampee otic", "rebampee oticrebampee otic", "medical supervision patients", "healthcare professional precautions", "acetylcysteine temporary increase", "mucosal protective agent", "medications herbal supplements", "cellular defense making", "supports nerve regeneration", "doctors dosage instructions", "optimal results follow", "simultaneously iron supplements", "dizziness skin rash", "ingredients work synergistically" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2137, "imageuri": "https://productimages.withfloats.com/actual/685bf1b95d6f047570824865.png", "tileimageuri": "https://productimages.withfloats.com/tile/685bf1b95d6f047570824865.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-06-25T12:55:17.97Z", "updatedon": "2026-01-01T06:58:06.179Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rebamipide-alpha-lipoic-acid-and-acetylcysteine-capsules/2137", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "REBAMPEE OTIC", "category": "GENERAL RANGE", "tags": [ "rebamipide alpha lipoic acid and acetylcysteine capsules", "rebamipide tablets uses in hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6666b9204058ee05c4a6bfb1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "dapoxetine 30mg", "description": "DAPOXETINE 30\nDapoxetine (30mg)\n\nDAPOXITIME 30 features dapoxetine hydrochloride, a short-acting selective serotonin reuptake inhibitor (SSRI) formulated exclusively for on-demand treatment of PE, unlike traditional antidepressants that require daily use. This tablet works by temporarily elevating serotonin levels in the brain's neural synapses, which modulates the ejaculatory reflex and delays the time to ejaculation without causing prolonged systemic effects. Manufactured for reliability, each film-coated tablet delivers precise 30mg dosing, making it suitable for men aged 18-64 experiencing consistent PE, defined as ejaculation within one minute of penetration.​\n\nAs a fast-acting option from Steris Healthcare Pvt Ltd, DAPOXITIME 30 absorbs quickly when taken 1-3 hours before anticipated sexual activity, peaking in efficacy within 1-2 hours and clearing the body rapidly to minimize accumulation. It stands out for its convenience—no daily regimen needed—allowing users to integrate it seamlessly into their lifestyles while preserving spontaneity in intimate moments.​\n\nPrimary Uses\nDAPOXITIME 30 primarily treats premature ejaculation, helping men extend intravaginal ejaculatory latency time (IELT) by 2-3 times compared to placebo in clinical settings. Doctors prescribe it for lifelong or acquired PE, where rapid ejaculation causes distress, reducing overall sexual satisfaction for both partners.​\n\nBeyond core treatment, it supports improved ejaculatory control during vaginal intercourse, addressing a condition affecting up to 30% of men globally. The medication proves effective across diverse demographics, with consistent results in pooled phase 3 trials showing enhanced patient-reported outcomes on control and distress.​\n\nKey Benefits\nDAPOXITIME 30 delivers multifaceted advantages, starting with significantly prolonged IELT, often from under a minute to over three minutes, fostering greater endurance and mutual pleasure.​\n\nEnhanced control over ejaculation empowers users with confidence, alleviating performance anxiety that perpetuates the PE cycle.​\n\nBoosts sexual satisfaction for couples by extending intercourse duration and strengthening emotional intimacy and relationship bonds.​\n\nReduces psychological burden, including frustration and avoidance of intimacy, leading to improved mental well-being.​\n\nOn-demand dosing offers flexibility, avoiding the side effects of chronic SSRI use while providing rapid onset for planned encounters.​\n\nClinically proven efficacy across trials, with benefits noticeable from the first dose and sustained reliability over multiple uses.​\n\nThese gains translate to real-world improvements, as men report higher partner satisfaction scores and diminished interpersonal distress.​\n\nPotential Side Effects\nWhile generally well-tolerated, DAPOXETINE 30 may cause mild, transient side effects in about 10-20% of users, primarily due to its serotonergic action.​\n\nCommon effects include:\n\nNausea or upset stomach, often resolving within hours.​\n\nDizziness or lightheadedness, especially when standing quickly.​\n\nHeadache, typically mild and short-lived.​\n\nDiarrhea, dry mouth, or insomnia.​\n\nLess frequent but serious reactions encompass syncope (fainting), particularly in those dehydrated or on interacting drugs; mood alterations like anxiety; or rare vision changes and seizures. Risk heightens with alcohol, recreational drugs, or concurrent use of PDE5 inhibitors like sildenafil—consult a physician to mitigate interactions.​\n\nDosage and Precautions\nTake one 30mg tablet orally with water, 1-3 hours prior to sexual activity, on an empty stomach for optimal absorption; maximum one dose per 24 hours. Avoid if a history of syncope, cardiac issues, bipolar disorder, or severe liver/kidney impairment exists.​\n\nPrecautions emphasize hydration, rising slowly from sitting positions, and abstaining from alcohol to curb orthostatic hypotension. Not for women, children under 18, or men over 65; discontinue if mania or severe mood shifts occur. Regular medical oversight ensures safe, effective use.​\n\nConclusion\nDAPOXITIME 30 revolutionizes PE management with its precise, evidence-backed mechanism, delivering control, satisfaction, and confidence where it matters most. By balancing efficacy against manageable risks, it empowers men to reclaim fulfilling intimacy—always under professional guidance for personalized outcomes.", "price": 185.0, "discountamount": 56.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "PE", "food", "Call", "dose", "brain", "ORDER", "SSRIs", "drugs", "class", "water", "Email", "Dosage", "control", "WhatsApp", "64 years", "adult men", "treatment", "DAPOXITIME", "full glass", "medication", "information", "Indications", "sterispharma", "sterisonline", "Administration", "sexual activity", "Dapoxetine 30mg", "serotonin levels", "one tablet (30mg", "premature ejaculation", "serotonin reuptake inhibitors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1635, "imageuri": "https://productimages.withfloats.com/actual/6666b922844f26002460f33a.png", "tileimageuri": "https://productimages.withfloats.com/tile/6666b922844f26002460f33a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-10T08:28:16.906Z", "updatedon": "2025-12-18T09:10:49.716Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/dapoxetine-30mg/1635", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DAPOXITIME 30", "category": "NEPHROLOGYRANGE", "tags": [ "DAPOXITIME 30 mg", "Dapoxetine 30mg", "Dapoxetine 30mg hindi", "Dapoxetine 30mg side effects", "", "dapoxetine 30 mg+tadalafil 10 mg", "", "Dapoxetine 30mg uses in Hindi", "serotonin levels in the brain.", "Dapoxetine 30mg", "sexual activity .peaking in efficacy within 1-2 hours and clearing the body rapidly to minimize accumulation.", "it supports improved ejaculatory control during vaginal intercourse." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }